Come up with a name for your new list and we'll add to it:
Mnemosyne Pharmaceuticals raised a round of funding on , . Investors include
Clal Biotechnology Industries.
Mnemosyne Pharmaceuticals is a drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders. The company is exploring …